Comorbidities and risk factors for COVID-19 in a group of Iraqi patients confirmed by real-time PCR test

المؤلفون

  • Z Abbas Uruk University, Department of Pharmacy
  • F Manhal Uruk University, Department of Pharmacy

The aim of the study was to identify characteristic risk factors predisposing to coronavirus disease 2019 (COVID-19) outbreak in a group of Iraqi patients in Baghdad City.  In this study, we included a total of 13411 persons who had been tested for COVID-19, supervised by Al-Razi Medical Center in Baghdad City during the period from June 20 to November 13, 2020. Cases were tested and divided into two groups according to the result of real-time RT-PCR test for COVID-19.   A total of 1781 positive cases were detected with confirmed COVID-19. Comorbidities in the study patients were identified as hypertension, diabetes mellitus and respiratory disorders. Hypertension was the most common comorbidity in COVID-19 patients followed by diabetes mellitus.  The results of this study showed that patients with comorbidities were significantly associated with positive RT-PCR results related to COVID-19. It was concluded that understanding the comorbidities enhance defining patients with COVID-19 at higher risk. Further research is needed to confirm and clarify the impact of the association of co-morbidities that accompany COVID-19.

الكلمات المفتاحية:

COVID-19، Comorbidities، Risk Factors، Real-time PCR

[1] Zhu, H., Wei, L., & Niu, P. (2020). The novel coronavirus outbreak in Wuhan, China. Global Health Research and Policy, 5(1). https://doi.org/10.1186/s41256-020-00135-6

[2] Javanbakht M, Babaee S. Tinnitus in COVID-19 Patients; a Case Study. Iran J War Public Health. 2021; 13 (1) :79-83 URL: http://ijwph.ir/article-1-991-en.html.

[3] Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., … Tan, W. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine, 382(8), 727–733. https://doi.org/10.1056/nejmoa2001017

[4] Wu, F., Zhao, S., Yu, B., Chen, Y. M., Wang, W., Song, Z. G., … Zhang, Y. Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269. https://doi.org/10.1038/s41586-020-2008-3

[5] De Almeida-Pititto, B., Dualib, P. M., Zajdenverg, L., Dantas, J. R., De Souza, F. D., Rodacki, M., & Bertoluci, M. C. (2020). Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: A meta-analysis. Diabetology and Metabolic Syndrome, 12(1). https://doi.org/10.1186/s13098-020-00586-4

[6] Wang, B., Li, R., Lu, Z., & Huang, Y. (2020). Does comorbidity increase the risk of patients with covid-19: Evidence from meta-analysis. Aging, 12(7), 6049–6057. https://doi.org/10.18632/AGING.103000

[7] Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., … Zhong, N. S. (2020). Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. https://doi.org/10.1101/2020.02.06.20020974

[8] Guan, W., Liang, W., Zhao, Y., Liang, H., Chen, Z., Li, Y., … He, J. (2020). Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. European Respiratory Journal, 55(5), 2000547. https://doi.org/10.1183/13993003.00547-2020.Supp1 .

[9] Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., … Altaf, M. (2020). Comorbidity and its Impact on Patients with COVID-19. SN Comprehensive Clinical Medicine, 2(8), 1069–1076. https://doi.org/10.1007/s42399-020-00363-4

[10] Hosseinzadeh, R., Goharrizi, M. A. S. B., Bahardoust, M., Alvanegh, A. G., Ataee, M. R., Bagheri, M., … Heiat, M. (2021). Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)? Clinical Hypertension, 27(1). https://doi.org/10.1186/s40885-021-00161-7

[11] Ernesto L Schiffrin, John M Flack, Sadayoshi Ito, Paul Muntner, R Clinton Webb. 2020. Hypertension and COVID-19. Am J Hypertens; 33(5):373-374. Doi: 10.1093/ajh/hpaa057.

[12] Alireza Arman, Maryam Tajik, Maryam Nazemipour, Zahra Ahmadinejad, Sahar Keyvanloo Shahrestanaki, Ebrahim Hazrati, Nasrin Mansournia, Mohammad Ali Mansournia. Risk factors of developing critical conditions in Iranian patients with COVID- 19. Global Epidemiology; 2021, Volume 3, 100046.

[13] Brunilda Nazario. 2021. Coronavirus and High Blood Pressure: What’s the Link? WebMD Medical Reference. https://www.webmd.com/lung/coronavirus-high-blood-pressure#1. 2021.

[14] Taqi Mohammed Jwad Taher, Firas Turki Rashed Sarray, Saad Abid al-badri, and Hasanain Faisal Ghazi. Comorbidity and Risk Factors for COVID-19 Confirmed Patients in Wasit Province, IRAQ. Al-Kindy College Medical Journal, 2020; 16(SUPP):1-8. DOI:10.47723/kcmj.v16isupplement.174.

[15] American Diabetes Association. How COVID-19 Impacts People with Diabetes. https://www.diabetes.org/coronavirus-covid-19/how-coronavirus-impacts-people-with-diabetes. 2021.

[16] Leon-Abarca, J. A., Portmann-Baracco, A., Bryce-Alberti, M., Ruiz-Sánchez, C., Accinelli, R. A., Soliz, J., & Gonzales, G. F. (2021). Diabetes increases the risk of COVID-19 in an altitude dependent manner: An analysis of 1,280,806 Mexican patients. PLoS ONE, 16(8 August). https://doi.org/10.1371/journal.pone.0255144

[17] Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., … Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7

[18] Onder, G., Rezza, G., & Brusaferro, S. (2020, May 12). Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA - Journal of the American Medical Association. American Medical Association. https://doi.org/10.1001/jama.2020.4683 .

[19] Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., … Altaf, M. (2020). Comorbidity and its Impact on Patients with COVID-19. SN Comprehensive Clinical Medicine, 2(8), 1069–1076. https://doi.org/10.1007/s42399-020-00363-4

[20] Leung, J. M., Niikura, M., Yang, C. W. T., & Sin, D. D. (2020, August 1). COVID-19 and COPD. European Respiratory Journal. European Respiratory Society. https://doi.org/10.1183/13993003.02108-2020

[21] Meza, D., Khuder, B., Bailey, J. I., Rosenberg, S. R., Kalhan, R., & Reyfman, P. A. (2021). Mortality from covid-19 in patients with copd: A us study in the n3c data enclave. International Journal of COPD. Dove Medical Press Ltd. https://doi.org/10.2147/COPD.S318000

Comorbidities and risk factors for COVID-19 in a group of Iraqi patients confirmed by real-time PCR test. (2021). Journal Port Science Research, 4(1), 1-5. https://doi.org/10.36371/port.2021.1

الرخصة

الحقوق الفكرية (c) 2021 Journal Port Science Research

Creative Commons License

هذا العمل مرخص بموجب Creative Commons Attribution-ShareAlike 4.0 International License.

كيفية الاقتباس

Comorbidities and risk factors for COVID-19 in a group of Iraqi patients confirmed by real-time PCR test. (2021). Journal Port Science Research, 4(1), 1-5. https://doi.org/10.36371/port.2021.1